Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amikacin sulfate 100mg/2mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin sulfate |
Inferred relationship |
Some |
|
Amikacin sulfate 1gram/4mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin sulfate |
Inferred relationship |
Some |
|
amikacine 100 mg/2 mL, pour injection pédiatrique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin sulfate |
Inferred relationship |
Some |
|
amikacine 250 mg/mL, fiole d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin sulfate |
Inferred relationship |
Some |
|
Product containing precisely amikacin (as amikacin sulfate) 100 milligram/2 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Amikacin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely amikacin (as amikacin sulfate) 500 milligram/2 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Amikacin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely amikacin (as amikacin sulfate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amikacin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely amikacin (as amikacin sulfate) 250 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amikacin sulfate |
Inferred relationship |
Some |
1 |
Amikacin sulfate 10 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amikacin sulfate |
Inferred relationship |
Some |
1 |
Amikacin sulfate 10 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amikacin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely amikacin (as amikacin sulfate) 125 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amikacin sulfate |
Inferred relationship |
Some |
1 |
Amikacin (as amikacin sulfate) 5 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amikacin sulfate |
Inferred relationship |
Some |
1 |
Amikacin (as amikacin sulfate) 250 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amikacin sulfate |
Inferred relationship |
Some |
1 |
Amikacin sulfate liposome |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Amikacin sulfate |
Inferred relationship |
Some |
|